Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Broom

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Cancer Research|July 30, 2017
<i>NSD1</i> Inactivation and <i>SETD2</i> Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell CarcinomasXiaoping Su, Jianping Zhang, Roger Mouawad, et al.
Molecular Cancer Therapeutics|May 5, 2017
Modeling of Patient-Derived Xenografts in Colorectal CancerAnastasia Katsiampoura, Kanwal Raghav, Zhi-Qin Jiang, et al.
Journal of the American Veterinary Medical Association|January 30, 2007
Thoughts on farm animal welfareBo Algers, Nils Lundeheim, Laura A Boyle, et al.
European Urology Oncology|November 14, 2021
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate CancerEstefania Labanca, Jun Yang, Peter D A Shepherd, et al.
Journal of Veterinary Medical Education|January 20, 2006
Approaches to teaching animal welfare at 13 veterinary schools worldwideCaroline J Hewson, Eva Baranyiová, Donald M Broom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate CancerWei Zhang, Bo Liu, Wenhui Wu, et al.
Molecular Cancer Therapeutics|June 23, 2021
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate CancerCheng Wu, Shan Peng, Patrick G Pilié, et al.
Cancer Research|October 10, 2014
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanomaY N Vashisht Gopal, Helen Rizos, Guo Chen, et al.
Nature Sustainability|November 20, 2018
The environmental costs and benefits of high-yield farmingAndrew Balmford, Tatsuya Amano, Harriet Bartlett, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Cancer Research|July 30, 2017
<i>NSD1</i> Inactivation and <i>SETD2</i> Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell CarcinomasXiaoping Su, Jianping Zhang, Roger Mouawad, et al.
Molecular Cancer Therapeutics|May 5, 2017
Modeling of Patient-Derived Xenografts in Colorectal CancerAnastasia Katsiampoura, Kanwal Raghav, Zhi-Qin Jiang, et al.
Journal of the American Veterinary Medical Association|January 30, 2007
Thoughts on farm animal welfareBo Algers, Nils Lundeheim, Laura A Boyle, et al.
European Urology Oncology|November 14, 2021
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate CancerEstefania Labanca, Jun Yang, Peter D A Shepherd, et al.
Journal of Veterinary Medical Education|January 20, 2006
Approaches to teaching animal welfare at 13 veterinary schools worldwideCaroline J Hewson, Eva Baranyiová, Donald M Broom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate CancerWei Zhang, Bo Liu, Wenhui Wu, et al.
Molecular Cancer Therapeutics|June 23, 2021
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate CancerCheng Wu, Shan Peng, Patrick G Pilié, et al.
Cancer Research|October 10, 2014
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanomaY N Vashisht Gopal, Helen Rizos, Guo Chen, et al.
Nature Sustainability|November 20, 2018
The environmental costs and benefits of high-yield farmingAndrew Balmford, Tatsuya Amano, Harriet Bartlett, et al.
Pageof 16